21 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 8 Phase 3, 7 Phase 4, 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Active not recruiting 1 |
| Phase 4 | 7 | Completed 5, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 5 | Completed 4, Unknown 1 |
Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer Ilaprazole, Lansoprazole, Ilaprazole Placebo - Peptic Ulcer | Phase 3 | Active not recruiting | Il-Yang Pharm. Co., Ltd. | 416 | 2024-07-23 | 2026-11-06 |
| Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage | Phase 4 | Not yet recruiting | West China Hospital | 672 | 2023-10-01 | 2023-09-28 |
| Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac Ilaprazole, Aceclofenac - Drug Interaction Potentiation | Phase 1 | Completed | Il-Yang Pharm. Co., Ltd. | 24 | 2022-11-10 | 2023-06-28 |
| Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole Ilaprazole, Naproxen, Aceclofenac - Drug Interaction Potentiation | Phase 1 | Completed | Il-Yang Pharm. Co., Ltd. | 72 | 2022-02-17 | 2023-06-28 |
| Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD Ilaprazole - Non-erosive Reflux Disease | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 277 | 2018-10-31 | 2021-01-05 |
| Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment amoxicillin, clarithromycin, tinidazole - Antimicrobial Susceptibility Testing, Triple Therapy | Phase 4 | Unknown | Yanqing Li | 120 | 2017-05-30 | 2017-05-03 |
| Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole Ilaprazole 10mg, Clarithromycin 500mg, Amoxicillin 500 Mg - Drug Interaction Potentiation | Phase 1 | Completed | Il-Yang Pharm. Co., Ltd. | 28 | 2016-12-01 | 2017-01-26 |
| The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients Ilaprazole, Amoxicillin, Clarithromycin - Peptic Ulcer | Phase 4 | Completed | Kyungpook National University Hospital | 50 | 2016-03-02 | 2018-08-09 |
| Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Ilaprazole, Rabeprazole - Gastric Cancer | Phase 4 | Completed | Il-Yang Pharm. Co., Ltd. | 176 | 2015-12-01 | 2020-07-31 |
| Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection Ilaprazole + Amoxicillin - Helicobacter Infections | Phase 4 | Completed | Il-Yang Pharm. Co., Ltd. | 90 | 2014-12-01 | 2015-11-03 |
| Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Ilaprazole, Omeprazole, Ilaprazole tablet - Peptic Ulcer Hemorrhage | Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 540 | 2014-10-01 | 2017-12-06 |
| Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori Ilaprazole, Esoprazole - Helicobacter Pylori Eradication | Phase 4 | Completed | Livzon Pharmaceutical Group Inc. | 2014-09-01 | 2016-08-19 | |
| The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker Ilaprazole - Gastrointestinal Subepithelial Tumors | Phase 4 | Completed | Yonsei University | 20 | 2014-07-01 | 2019-03-22 |
| IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Ilaprazole, omeprazole - Peptic Ulcer Hemorrhage | Phase 2 | Completed | Livzon Pharmaceutical Group Inc. | 180 | 2014-02-01 | 2017-12-06 |
| Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori Noltec tab. 10mg, Chongkundang Amoxicillin Cap. 500mg, Cravit Tab. 500mg - Helicobacter Infections | Completed | Il-Yang Pharm. Co., Ltd. | 320 | 2012-12-01 | 2015-08-27 | |
| Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment Ilaprazole, Pantoprazole - Peptic Ulcer | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 323 | 2012-12-01 | 2014-06-03 |
| Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients 10 mg ilaprazole, 40mg esomeprazole - Gastroesophageal Reflux Disease | Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 550 | 2011-12-01 | 2016-08-09 |
| Efficacy Study of Ilaprazole to Treat Erosive Esophgitis Ilaprazole, Lansoprazole - Erosive Esophagitis, GERD | Phase 3 | Completed | Il-Yang Pharm. Co., Ltd. | 292 | 2010-07-01 | 2012-01-12 |
| Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients 10 mg ilaprazole, 15 mg ilaprazole, 40 mg esomeprazole - Gastroesophageal Reflux Disease | Phase 2 | Unknown | Livzon Pharmaceutical Group Inc. | 330 | 2010-05-01 | 2010-04-21 |
| Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism Ilaprazole - Healthy | Phase 1 | Completed | Inje University | 27 | 2009-01-01 | 2012-09-20 |
Showing 20 of 25. Sign in to see all of them.
Gastroesophageal Reflux (4) · Duodenal Ulcer (3) · Peptic Ulcer (3) · Helicobacter Infections (2) · Peptic Ulcer Hemorrhage (2) · Esophagitis (1) · Gastrointestinal Hemorrhage (1) · Heartburn (1) · Liver Cirrhosis (1) · Non-Erosive Reflux Disease (1) · Stomach Neoplasms (1)
Il-Yang Pharm. Co., Ltd. (11) · Livzon Pharmaceutical Group Inc. (8) · Inje University (1) · Kyungpook National University Hospital (1) · Takeda (1) · West China Hospital (1) · Yanqing Li (1) · Yonsei University (1)
South Korea (12) · China (2) · Canada (1) · United States (1)
Minsoo Park, PhD (2) · S R Lin, M.D (2) · ChangSeok Bang, MD, PhD (1) · DongHo Lee, MD.PhD (1) · Dongsoo Lee, MD, PhD. (1) · Gaetano Morelli, MD (1) · JaeGook Shin, MD,PhD (1) · JungSoo Song, M.D. (1) · Kim JinHo (1) · Li Yanqing, MD, PhD (1) · Liya Zhou, MD (1) · Min MS Park, PhD (1) · Sanren Lin, MD (1)
PMID 20679904, PMID 22070512, PMID 27605258, PMID 29540336, PMID 29846770, PMID 30167954, PMID 38910891